Background: Allergic and non-allergic childhood asthma has been characterized by
| INTRODUCTION
Asthma is the most common chronic airway inflammatory disease in children 1 and is characterized by reversible airflow obstruction and bronchial hyperresponsiveness, being influenced by environmental factors, genetic predisposition, and subsequent immune modulation. 2 We have demonstrated that children with allergic (AA) and non-allergic asthma (NA) were characterized by distinct immune-regulatory mechanisms. 3 However, modifications of immune-regulatory mechanisms by genetic background have not been fully elucidated. One important candidate is interferon regulating factor 1 (IRF-1), as Schedel et al. 4 have shown that genetic variants in IRF-1 influence the development of childhood atopy and IgE regulation. Furthermore, IRF-1 levels in AA were reduced upon rhinovirus stimulation compared to healthy controls. 5 The IRF transcription factors (TF) were originally identified in the context of type I interferon regulation. 6 In this study, we now aimed to investigate whether human IRF-1 genetic variants modify specific immune-regulatory pathways in children with allergic and non-allergic asthma compared to healthy controls.
| METHODS

| Study population
The CLARA study population comprised 4-to 15-year-old steroidnaïve AA, NA, and HC (healthy control) children (n = 273), described previously. 3 Genotyping, cytokine analyses, and RT-PCR were performed in a subgroup of children (N = max 172), comparable to the whole study population. Asthmatic children were characterized by clinical examination, body plethysmography, fractional exhaled nitric oxide (FeNO), full blood count, total and specific IgE (Allergy Screen ® , Mediwiss Analytic GmbH), and defined according to GINA guidelines. 12, 13 Inclusion criteria for AA/NA were recurrent obstructive bronchitis and/or doctor's diagnosis of asthma and/or history of asthma medication and a lung function indicating significant reversible airflow obstruction. The classification in AA/NA was based on positive (spec. IgE ≥ 0.35 IU/mL) or negative allergic sensitization, in accordance with clinical symptoms. HC had no allergies and were in the same age range. Exclusion criteria for all children comprised other chronic, pulmonary, and autoimmune diseases; immunodeficiency; intake of steroids; antibiotics; probiotics; and infection within 14 days before blood withdrawal. 4 The study population was genotyped for four of these tagging SNP, which were significantly associated with changes in total IgE levels. 4 Genomic DNA was extracted from whole blood (Flexigene DNA-Kit, Qiagen, Hilden, Germany). Samples were genotyped using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (Sequenom, Inc., San Diego, CA). Deviations from Hardy-Weinberg equilibrium were assessed for quality control of genotyping procedures.
| SNP selection and genotyping
| Isolation and culture of PBMCs and quantitative RT-PCR
Peripheral blood mononuclear cells (PBMCs) were isolated within 24 hours after blood withdrawal, cultured unstimulated (M) or stimulated with plate-bound anti-CD3 (3 μg/mL) plus soluble anti-CD28
(1 μg/mL) or lipid A (LpA, 0.1 μg/mL). Cell pellets were used for RNA isolation and supernatants for cytokine measurements. RNA isolated with RNeasy Mini-Kit was processed (1 μg) with reverse transcriptase (Qiagen). Gene-specific PCR products were measured by CFX96 TouchTM Real-time PCR Detection System (Bio-Rad, Munich, Germany) for 40 cycles (details in Supporting information).
| Statistical analyses
Clinical/laboratory characteristics of the genotyped population were described with 25, 50, and 75th percent quartiles. 
| RESULTS
| Clinical characteristics of genotyped study population
Children with allergic (AA) and/or non-allergic asthma (NA) compared to healthy controls (HCs) significantly differed in clinical and laboratory parameters as previously reported. 3 AA had increased eosinophils, IgE, and FeNO compared to NA and HC. Trendwise increased neutrophils were detected in NA (P ≤ .1, Table 1 ). Both AA and NA had significantly lower z-scores for FEV 1 and FEV 1 /FVC ratio and significantly higher bronchodilator response compared to HCs. The groups were comparable in terms of epidemiological characteristics.
| Description of IRF-1 polymorphisms
SNP characteristics were displayed in OR Table S1 . Success rate for genotyping was between 98 and 100%. None of the alleles significantly deviated from HWE. The MAF of analyzed tagging SNPs was comparable with the European population indicated by National
Center for Biotechnology Information (NCBI) [15] [16] [17] [18] (OR. Table S1 ).
Changes in TF-binding patterns are described in Supporting information (OR. Table S7 ).
| Association of IRF-1 genotypes with childhood asthma
The association of the four IRF-1 SNPs with asthma prevalence was shown in Table 2 . Homozygous carriers of the three IRF-1 SNPs rs2706384, rs2070721, rs10035166 had a higher risk being AA compared to HC. These alleles are called "risk alleles" subsequently.
Homozygous carriers of rs17622656 were significantly less prevalent in AA compared to HC, subsequently called "protective alleles."
Homozygous carriers of rs17622656 were significantly more prevalent in the NA compared to AA. There were no significant differences between HC and NA children. Figure 1 shows the distribution of children with different risk scores. Relating the risk score to the proportion of AA resulted in a highly significant OR ( Figure 1 ).
| Influence of IRF-1 genotype on immune regulation
We analyzed potential underlying immune regulation by gene expression and cytokine secretion (all details on cytokines in Supporting information, including method, results S2A, S2B, S2C, and discussion).
Due to our prior findings, 3 Total N may differ slightly due to available data; eosinophils, percentage of blood eosinophils; neutrophils, percentage of blood neutrophils; IgE, total serum immunoglobulin E; FEV was seen for NOD2 (partly down and up-regulation), RGS13, RORC,
IRF-8, IFN-γ, ICAM-3, FCRL5
, and XBP-1 (upregulated, Figure 2A , details OR. Table S6 ). Figure 2B shows scatter plots of unstimulated (M) gene expression depending on increasing risk score for AA and HC with significant different slopes for HC compared to AA.
| Gene regulation in NA children with IRF-1 SNP
NA with risk allele in rs2070721 showed upregulated gene expression in calcium-, innate-, m-TOR-, neutrophil-, and inflammatoryassociated genes. Conversely, NA with non-risk allele rs17622656
showed significant downregulation of these pathways, thus expressing the opposite gene regulation pattern (OR . Table S3C ).
| DISCUSSION
Previously, we identified distinct immune-regulatory mechanisms in AA and NA children, namely decreased expression of genes associated with innate immunity and increased pro-inflammatory IL-1β
and IL-17-shifted neutrophilic inflammation. In this study, we now 
| Increased risk for childhood AA with IRF-1 polymorphisms
A cross-sectional cohort study of German children identified genetic variants in IRF-1 to be associated with atopy and increased IgE. 4 Also, in a Japanese population, IRF-1 polymorphisms in intron 1 and intron 7 were associated with atopic asthma in children. 19 IRF-1 in combination with IRF-4 was previously shown to regulate Th9 cells. 20 In our cohort, the IRF-1 polymorphic alleles rs2706384, rs2070721, and rs10035166 were associated with increased risk for AA but not for NA. The polymorphic allele rs17622656 was associated with protection from AA, in concordance with the decreased risk for atopy and atopic asthma described by Schedel et al. 4 Of note, other factors beyond IRF-1 risk alleles contribute to asthma, as also risk allele carriers were HC and vice versa children with WT allele for IRF-1 were AA.
Aiming to disentangle underlying immune-regulatory pathways of children with IRF-1 polymorphic allele with asthma, we measured cytokine secretion (Supporting information) and gene expression for inflammatory signaling pathways, mTOR regulation, Treg/Th17-associated genes, innate receptors and regulators, and calcium signaling molecules in AA, NA, and HC children. Ca-signaling. 30 An overshooting adaptive immune response might be attenuated at the onset of asthma development, but this needs to be proven by further experiments.
| Pro-inflammatory gene expression in
| NAs showed upregulation of distinct immuneregulatory pathways with risk allele in rs2070721
The alleles associated with higher risk for AA did not change the risk for NA but do influence gene expression. Collectively, NA carriers of the polymorphic allele in rs17622656 showed downregulation of several genes, while vice versa NA with the polymorphic allele rs2070721 showed upregulation of selected genes. Specifically, this comprised genes of the calcium, innate immunity pathway, inflammatory, and neutrophil-associated genes. The strength of this study is a well-defined asthma cohort including exclusively steroid-naïve asthmatics with strict in-and exclusion criteria.
Of note, an unequal distribution of NA vs AA is prevalent in this study as shown before. 
